The most abundant subtype of cerebral nicotinic acetylcholine receptors (nAChR), alpha4beta2, plays a critical role in various brain functions and pathological states. Imaging agents suitable for visualization and quantification of alpha4beta2 nAChRs by positron emission tomography (PET) would present unique opportunities to define the function and pharmacology of the nAChRs in the living human brain. In this study, we report the synthesis, nAChR binding affinity, and pharmacological properties of several novel 3-pyridyl ether compounds. Most of these derivatives displayed a high affinity to the nAChR and a high subtype selectivity for alpha4beta2-nAChR. Three of these novel nAChR ligands were radiolabeled with the positron-emitting isotope (11)C and evaluated in animal studies as potential PET radiotracers for imaging of cerebral nAChRs with improved brain kinetics.
The most abundant subtype of cerebral nicotinic acetylcholine receptors (n class="Gene">nAChR), alpha4beta2, plays a critical role in various brain functions and pathological states. Imaging agents suitable for visualization and quantification of alpha4beta2 nAChRs by positron emission tomography (PET) would present unique opportunities to define the function and pharmacology of the nAChRs in the living human brain. In this study, we report the synthesis, nAChR binding affinity, and pharmacological properties of several novel 3-pyridyl ether compounds. Most of these derivatives displayed a high affinity to the nAChR and a high subtype selectivity for alpha4beta2-nAChR. Three of these novel nAChR ligands were radiolabeled with the positron-emitting isotope (11)C and evaluated in animal studies as potential PET radiotracers for imaging of cerebral nAChRs with improved brain kinetics.
Authors: Sascha Mitkovski; Victor L Villemagne; Kathy E Novakovic; Graeme O'Keefe; Henri Tochon-Danguy; Rachel S Mulligan; Kerryn L Dickinson; Tim Saunder; Marie-Claude Gregoire; Michel Bottlaender; Frederic Dolle; Christopher C Rowe Journal: Nucl Med Biol Date: 2005-08 Impact factor: 2.408
Authors: Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson Journal: J Cereb Blood Flow Metab Date: 2007-05-09 Impact factor: 6.200
Authors: F Doll; L Dolci; H Valette; F Hinnen; F Vaufrey; I Guenther; C Fuseau; C Coulon; M Bottlaender; C Crouzel Journal: J Med Chem Date: 1999-06-17 Impact factor: 7.446
Authors: LaVerne Brown; Svetlana Chefer; Olga Pavlova; D Bruce Vaupel; Andrei O Koren; Alane S Kimes; Andrew G Horti; Alexey G Mukhin Journal: J Neurochem Date: 2004-11 Impact factor: 5.372
Authors: Adebowale E Ogunjirin; Joseph M Fortunak; LaVerne L Brown; Yingxian Xiao; Martha I Dávila-García Journal: Neurochem Res Date: 2015-10-27 Impact factor: 3.996